Product Information

HADLIMA(CF) 40 MG/0.4 ML SYRINGE is a brand biologic product labeled by Organon LLC, priced at $1257.0715 per ML under NDC 78206018601. Its NADAC has been published 80 times since Dec 18, 2024.

HADLIMA(CF) 40 MG/0.4 ML SYRINGE

adalimumab-bwwd
$1257.0715per ML

Strength

40 mg/.4mL

Manufacturer

Organon LLC

NDC

78206018601

Classification

Brand Biologic

Dosage Form

SOLUTION

Route

SUBCUTANEOUS

Last Updated

6/17/2026

Active Ingredients

ADALIMUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA761059

On Market Since

7/1/2023

Pharmacological Classes

Antibodies
Monoclonal
Tumor Necrosis Factor Blocker
Tumor Necrosis Factor Receptor Blocking Activity

Price Statistics

The NADAC for HADLIMA(CF) 40 MG/0.4 ML SYRINGE has been published 80 times since Dec 18, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$1257.0715 per ML
All-time high$1260.7425 (Feb 11, 2026)
All-time low$1256.0094 (Sep 17, 2025)
52-week high$1260.7425
52-week low$1256.0094
Median price$1259.0481
Average price$1258.4323
Largest weekly change-0.3% (Sep 17, 2025)
Weeks tracked80
Tracking sinceDec 18, 2024

Price History

1W

0.0%

1M

-0.0%

3M

-0.2%

6M

-0.2%

1Y

-0.2%

3Y

N/A

5Y

N/A

All

+0.1%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 50% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 50%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of HADLIMA(CF) 40 MG/0.4 ML SYRINGE?

The current National Average Drug Acquisition Cost (NADAC) for HADLIMA(CF) 40 MG/0.4 ML SYRINGE, manufactured by Organon LLC, is $1257.0715 per ML (NDC 78206018601), effective Jun 24, 2026.

How has the price of HADLIMA(CF) 40 MG/0.4 ML SYRINGE changed over time?

Over the history we have for it, the NADAC for HADLIMA(CF) 40 MG/0.4 ML SYRINGE has held within roughly two percent of its current level. It has been tracked across 80 weekly CMS publications since Dec 18, 2024.

What are the highest and lowest recorded NADAC prices for HADLIMA(CF) 40 MG/0.4 ML SYRINGE?

Since Dec 18, 2024, the NADAC for HADLIMA(CF) 40 MG/0.4 ML SYRINGE has ranged from a low of $1256.0094 (Sep 17, 2025) to a high of $1260.7425 (Feb 11, 2026), with a median of $1259.0481 per ML.

Are there cheaper alternatives to HADLIMA(CF) 40 MG/0.4 ML SYRINGE?

Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, HADLIMA PUSHTOUCH 40 MG/0.8 ML, is $634.4750 per ML — about 50% below HADLIMA(CF) 40 MG/0.4 ML SYRINGE.

Who manufactures HADLIMA(CF) 40 MG/0.4 ML SYRINGE?

HADLIMA(CF) 40 MG/0.4 ML SYRINGE (NDC 78206018601) is labeled by Organon LLC, and CMS classifies it as a brand biologic product.